
Péptidos y Proteínas
Los péptidos son cadenas cortas de aminoácidos unidas por enlaces peptídicos, mientras que las proteínas son cadenas más largas y complejas de aminoácidos que pueden adoptar estructuras tridimensionales funcionales. Ambos tipos de compuestos son esenciales para diversas funciones biológicas, como la catalización de reacciones (enzimas), la defensa inmunológica (anticuerpos) y la señalización celular. Las proteínas tienen una estructura jerárquica, que incluye la secuencia de aminoácidos, la estructura secundaria, terciaria y cuaternaria. Los péptidos se utilizan en terapias farmacológicas y cosméticas por sus propiedades biológicas específicas, como en el tratamiento de enfermedades metabólicas o la mejora de la regeneración celular. Las proteínas, por su parte, tienen aplicaciones en biotecnología, nutrición y medicina regenerativa.
En CymitQuimica ofrecemos péptidos y proteínas de alta pureza para investigación en biotecnología y aplicaciones terapéuticas.
Se han encontrado 3117 productos de "Péptidos y Proteínas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Boceprevir-d9
CAS:Producto controlado<p>Applications A labelled NS3 serine protease inhibitor of hepatitis C virus. It is a COVID19-related research product.<br>References Malcolm, B., et al.: Antimicrob. Agents Chemother., 50, 1013 (2006); Cubero, M., et al.: Virology, 370, 237 (2008); Venkatraman, S., et al.: J. Med. Chem., 49, 6074 (2006);<br></p>Fórmula:C272H9H36N5O5Forma y color:NeatPeso molecular:528.73(D-His2)-Leuprolide Trifluoroacetic Acid Salt
CAS:Producto controlado<p>Impurity Leuprolide Acetate EP Impurity B TFA salt<br>Applications Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal).<br>References Vilchez-Martinez, J.A., et al.: Biochem. Biophys. Res. Commun., 59, 1226 (1974), Sennello, L.T., et al.: J. Pharm. Sci., et al.: 75, 158 (1986), Wheeler, J.M., et al.: Am.J. Obstet. Gynecol., 167, 1367 (1992), Eri, L.M., et al.: J. Urol., 150, 359 (1993),<br></p>Fórmula:C59H84N16O12·x(C2HF3O2)Forma y color:NeatPeso molecular:1209.3982-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid
<p>Applications 2-((4S,7S,10S,13S,15R)-10-Benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-1-morpholino-2,5,8,11,14,18-hexaoxo-4-phenethyl-17-oxa-3,6,9,12-tetraazanonadecan-19-yl)-2-hydroxysuccinic Acid is an impurity of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.<br>References Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);<br></p>Fórmula:C46H65N5O14Forma y color:White To Off-WhitePeso molecular:912.033Voclosporin M1 (IM1-Diol-1) metabolite
Fórmula:C63H113N11O14Pureza:>85%Forma y color:NeatPeso molecular:1248.66N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib
CAS:Producto controlado<p>Applications N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H22N4O3Forma y color:White To Off-WhitePeso molecular:354.403(S)-Hydroxy Des(boric Acid) Bortezomib
CAS:Producto controlado<p>Impurity Bortezomib USP Impurity J<br>Applications (S)-Hydroxy Des(boric Acid) Bortezomib is an impurity in the synthesis of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl, C. et al.: Chem. and Eng. News, 87, 41 (2009)<br></p>Fórmula:C19H24N4O3Forma y color:NeatPeso molecular:356.42(S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Producto controlado<p>Applications (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Forma y color:NeatPeso molecular:372.42Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Lisinopril (L468985) impurity.<br>References Drummer, O., et al.: Arzneim.-Forsch. Drug Res., 38, 647 (1988), Simpson, K., et al.: Drugs, 59, 1149 (2000),<br></p>Fórmula:C21H29N3O4Forma y color:NeatPeso molecular:387.47(S)-4-Oxo-homophenylalanine Hydrochloride
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications (S)-4-Oxo-homophenylalanine Hydrochloride is a derivative of L-Homophenylalanine (H600500); an antitumor agent.<br>References Brunner, Henri., et al.: Eur. J. Med. Chem., 25, 35 (1990)<br></p>Fórmula:C10H12ClNO3Forma y color:NeatPeso molecular:229.669-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin
CAS:Producto controlado<p>Applications 9-(2,5-d|Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin is a stereoisomer of Daptomycin (D193350), cyclic lipopeptide antibiotic derived from a fermentation product of Streptomyces roseosporus; disrupts plasma membrane function in gram-positive bacteria. Antibacterial.<br>References Allen, N.E., et al.: Antimicrob. Agents Chemother., 31, 1093 (1987), Tully, F.P., et al.: Expert Opin. Invest. Drugs, 8, 1223 (1999),<br></p>Fórmula:C72H99N17O25Forma y color:NeatPeso molecular:1602.66(S)-N-[1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2yl]pyrazine-2-carboxamide
Producto controladoFórmula:C19H22N4O4Forma y color:NeatPeso molecular:370.4N-Nitroso-D,L-proline-d3
CAS:Producto controlado<p>Applications A labelled nitrosoamino acid with oncogenic activity.<br>References Nagasawa, H.T., et al.: J. Med. Chem., 16, 583 (1973)<br></p>Fórmula:C52H3H5N2O3Forma y color:Off-WhitePeso molecular:147.147t-Butyl 4-Bromobutanoate
CAS:Producto controlado<p>Applications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.<br>References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)<br></p>Fórmula:C8H15BrO2Forma y color:NeatPeso molecular:223.11N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Producto controlado<p>Applications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Fórmula:C31H41N3O7Forma y color:NeatPeso molecular:567.67Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Producto controlado<p>Applications An impurity of Clomiphene (C587025).<br></p>Fórmula:C26H29Cl2NOForma y color:NeatPeso molecular:442.42(AlphaS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
CAS:Producto controlado<p>Impurity Lopinavir EP Impurity R<br>Applications (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide (Lopinavir EP Impurity R) is an impurity of Lopinavir (L469480), a selective HIV protease inhibitor.<br>References Chitturi, S.R., et al.: J. Pharma. Biomed. Anal., 48, 1430 (2008); Devi, A.S.L., et al.: Magnet. Reson. Chem., 45, 424 (2007);<br></p>Fórmula:C47H58N4O7Forma y color:NeatPeso molecular:791.0Lopinavir Metabolite M-3/M-4
CAS:Producto controlado<p>Applications A major metabolite of Lopinavir (L469480) . It is a COVID19-related research product.<br>References Molla, A., et al.: J. Virology, 250, 255 (1998), Sham, H., et al.: Antimicrob. Agents Chemother., 42, 3218 (1998), Kumar, G., et al.: Drug Metab. Dispos., 27, 86 (1999),<br></p>Fórmula:C37H48N4O6Forma y color:NeatPeso molecular:644.80Dodecyl Polyoxyethylene (23) Aldehyde
CAS:Producto controlado<p>Applications Polyoxyethylene (23) Lauric Acid is an intermediate in the synthesis of Bril L-23 Proline (LIFETC1), a polyethylene glycol derivative of Proline (P755995), an amino acid and precursor (with vitamin C) for collagen, the building block of the structure of tendons, ligaments, arteries, veins and muscles.<br>References Bondarenko, L.B., et al.: Int. J. Peptides., 2, 1687 (2012); Rimer, T., et al.: Biomacromolecules, 13, 2110 (2012);<br></p>Fórmula:C14H28O2(C2H4O)nForma y color:Neat(S,S)-Hydroperoxy Des(boric Acid) Bortezomib
CAS:Producto controlado<p>Impurity Bortezomib USP Impurity L<br>Stability Unstable in Methanol<br>Applications (R)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009);<br></p>Fórmula:C19H24N4O4Forma y color:White To Off-WhitePeso molecular:372.425-Oxo-L-proline-d5
CAS:Producto controlado<p>Applications 5-Oxo-L-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.<br>References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);<br></p>Fórmula:C52H5H2NO3Forma y color:White To Off-WhitePeso molecular:134.14
